Carboquone (also known as carbocisteine) is a medication that is used to treat the symptoms of chronic bronchitis and other upper respiratory tract diseases. It is a mucolytic agent, meaning it helps to break down and thin mucus, making it easier to cough it up. It is also used to reduce the viscosity of sputum in patients with cystic fibrosis. Carboquone works by inhibiting the production of mucus in the respiratory tract and decreasing the amount of mucus that is produced. Side effects may include nausea, vomiting, and abdominal pain.
Carboquone is a medication used in chemotherapy to treat certain types of cancer. Here's a summary of its key points:
Function:
- Alkylating agent: It belongs to a class of drugs known as alkylating agents, which work by damaging the DNA of cancer cells, preventing them from multiplying and ultimately leading to their death.
Development:
- Developed in 1970.
- Initial studies showed promising anti-tumor effectiveness, but further development seems to have been discontinued.
Availability:
- Limited information: Currently, there is limited information available regarding its present-day use or marketing status. It's crucial to consult with a healthcare professional for any specific details regarding its use.
Important to note:
- Due to the limited information available, it's essential to consult with a licensed physician for any questions or concerns regarding Carboquone, especially regarding its use, potential side effects, and any ongoing clinical trials or research.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01A - Alkylating agents
L01AC Ethylene imines
ATC Code
External Links
Carboquone